AMLX AI forecast — Amylyx Pharmaceuticals, Inc.

Hedgewing's neural-network ensemble rates AMLX a Buy as of . 1-day forecast: $30.69 (+4.00%). Last close $29.49 (-2.16%).

5-day and 20-day price targets, model confidence, and the full AI analysis are available with a free account.